HIV drug that protects a fetus should be avoided for one year after childbirth, researchers say

A new study found that while nevirapine works well to prevent mother-to-child HIV transmission, a single dose of nevirapine in infected pregnant women can trigger resistance to some forms of the AIDS-drug cocktail (antiretrovirals). This nevirapine-induced resistance fades after about 12 months and no longer hinders the cocktail, UAB researchers say.

Read the whole article on Science Daily

More from Science Daily